Highlights
- •5-lipoxygenase (5-LO) catalyzes the conversion of 20:4 n-3 into novel oxygenated metabolites.
- •Metabolites identified as Δ17-8‑hydroxy‑eicosatetraenoic acid (Δ17-8-HETE) and Δ17-8,15-dihydroxy-eicosatetraenoic acid (Δ17-8,15-diHETE).
- •Δ17-8,15-diHETE biosynthesis is inhibited by LTA4 hydrolase inhibitor SC 57461A.
- •Δ17-8,15-diHETE inhibits arachidonic acid-induced autocrine neutrophil stimulation and LTB4-induced neutrophil chemotaxis.
Abstract
5-lipoxygenase (5-LO) catalyzes the conversion of arachidonic acid (AA) into pro-inflammatory
leukotrienes. N-3 PUFA like eicosapentaenoic acid are subject to a similar metabolism
and are precursors of pro-resolving mediators. Stearidonic acid (18:4 n-3, SDA) is
a plant source of n-3 PUFA that is elongated to 20:4 n-3, an analogue of AA. However,
no 5-LO metabolites of 20:4 n-3 have been reported. In this study, control and 5-LO-expressing
HEK293 cells were stimulated in the presence of 20:4 n-3. Metabolites were characterized
by LC-MS/MS and their anti-inflammatory properties assessed using AA-induced autocrine
neutrophil stimulation and leukotriene B4-mediated chemotaxis. 8‑hydroxy‑9,11,14,17-eicosatetraenoic acid (Δ17-8-HETE) and 8,15-dihydroxy-9,11,13,17-eicosatetraenoic acid (Δ17-8,15-diHETE) were identified as novel metabolites. Δ17-8,15-diHETE production was inhibited by the leukotriene A4 hydrolase inhibitor SC 57461A. Autocrine neutrophil leukotriene stimulation and neutrophil
chemotaxis, both BLT1-dependent processes, were inhibited by Δ17-8,15-diHETE at low nM concentrations. These data support an anti-inflammatory role
for Δ17-8,15-diHETE, a novel 5-LO product.
Keywords
- Abbreviations: 19-OH-PGB2, 19(R)-hydroxy-prostaglandin B2
- AA, arachidonic acid
- ADA, adenosine deaminase
- ALA, alpha-linolenic acid
- BLT1, leukotriene B4 receptor 1
- DHA, docosahexaenoic acid
- DPA, docosapentaenoic acid
- ETA, eicosatetraenoic acid
- EtOH, ethanol
- HpETE, hydroperoxyeicosatetraenoic acid
- LO, lipoxygenase
- LTA4, leukotriene A4
- LTB4, leukotriene B4
- LTC4, leukotriene C4
- MeOH, methanol
- NEM, N-ethylmaleimide
- RP-HPLC, reverse phase-HPLC
- SDA, stearidonic acid
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Prostaglandins, Leukotrienes and Essential Fatty AcidsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.Ann. Intern. Med. 2013; 158: 515-525https://doi.org/10.7326/0003-4819-158-7-201304020-00003
- Conversion of α;-linolenic acid to longer-chain polyunsaturated fatty acids in human adults.Reprod. Nutr. Dev. 2005; 45: 581-597https://doi.org/10.1051/rnd:2005047
- Consumption of Buglossoides arvensis seed oil is safe and increases tissue long-chain n-3 fatty acid content more than flax seed oil—results of a phase I randomised clinical trial.J. Nutr. Sci. 2016; 5: e2https://doi.org/10.1017/jns.2015.34
- Consumption of echium oil increases EPA and DPA in blood fractions more efficiently compared to linseed oil in humans.Lipids Health Dis. 2016; 15: 32https://doi.org/10.1186/s12944-016-0199-2
- Dietary buglossoides arvensis oil increases circulating n-3 polyunsaturated fatty acids in a dose-dependent manner and enhances lipopolysaccharide-stimulated whole blood interleukin-10—a randomized placebo-controlled trial.Nutrients. 2017; 9: e261https://doi.org/10.3390/nu9030261
- Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.Curr. Top Med. Chem. 2007; 7: 311-340
- Lipoxygenase and Leukotriene pathways: biochemistry, biology, and roles in disease.Chem. Rev. 2011; 111: 5866-5898https://doi.org/10.1021/cr200246d
- Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.Clin. Chem. 2012; 58: 1476-1484https://doi.org/10.1373/clinchem.2012.190199
- Novel n-3 immunoresolvents: structures and actions.Sci. Rep. 2013; 3: 1940https://doi.org/10.1038/srep01940
- Resolvins and protectins in inflammation resolution.Chem. Rev. 2011; 111: 5922-5943https://doi.org/10.1021/cr100396c
- Metabolism of 8,11,14,17-eicosatetraenoic acid by human platelet lipoxygenase and cyclooxygenase.Biochim. Biophys. Acta. 1987; 920: 94-101
- Isolation of two novel E prostaglandins in human seminal fluid.J. Biol. Chem. 1986; 261: 2675-2683
- Biosynthesis of a novel prostaglandin. Δ 17 -PGE1, in the ram.Acta Physiol. Scand. 1986; 127: 45-49https://doi.org/10.1111/j.1748-1716.1986.tb07874.x
- The intracellular localisation and phosphorylation profile of the human 5-lipoxygenase δ13 isoform differs from that of its full length counterpart.PLoS ONE. 2015; 10 (e0132607)https://doi.org/10.1371/journal.pone.0132607
- Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes.Eur. J. Biochem. 1995; 232: 37-46
- On the cellular metabolism of the click chemistry probe 19-alkyne arachidonic acid.J. Lipid Res. 2016; 57: 1821-1830https://doi.org/10.1194/jlr.M067637
- Electrospray ionization and low energy tandem mass spectrometry of polyhydroxy unsaturated fatty acids.J. Am. Soc. Mass Spectrom. 1996; 7: 140-149https://doi.org/10.1016/1044-0305(95)00628-1
- Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.Br. J. Pharmacol. 1994; 111: 852-860
- Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4).Mol. Pharmacol. 1999; 56: 1055-1062
- The endocannabinoid 2-arachidonoyl-glycerol activates human neutrophils: critical role of its hydrolysis and de novo leukotriene b4 biosynthesis.J. Immunol. 2011; 186: 3188-3196https://doi.org/10.4049/jimmunol.1002853
- Omega-3 fatty acids and inflammatory processes: from molecules to man.Biochem. Soc. Trans. 2017; 45: 1105-1115https://doi.org/10.1042/BST20160474
- Dietary echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans.J. Nutr. 2004; 134: 1406-1411https://doi.org/10.1093/jn/134.6.1406
- Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases.J. Biol. Chem. 1976; 251: 7816-7820
- Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids.Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 3213-3217
- Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid.J. Biol. Chem. 1979; 254: 2643-2646
- Transformation of arachidonic acid in leukocytes. Isolation and structural analysis of a novel dihydroxy derivative.Prostaglandins Med. 1981; 6: 557-570
- Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolase.J. Biol. Chem. 1985; 260: 10966-10970
- Products derived from 5,8,11-eicosatrienoic acid by the 5-lipoxygenase-leukotriene pathway.J. Biol. Chem. 1983; 258: 12797-12800
- Are dietary recommendations for the use of fish oils sustainable?.CMAJ. 2009; 180: 633-637https://doi.org/10.1503/cmaj.081274
- Long-chain omega-3 oils-an update on sustainable sources.Nutrients. 2010; 2: 572-585https://doi.org/10.3390/nu2060572
- n-3 oil sources for use in aquaculture–alternatives to the unsustainable harvest of wild fish.Nutr. Res. Rev. 2008; 21: 85-96https://doi.org/10.1017/S0954422408102414
Article info
Publication history
Published online: October 15, 2018
Accepted:
October 13,
2018
Received in revised form:
October 4,
2018
Received:
August 14,
2018
Identification
Copyright
© 2018 Elsevier Ltd. All rights reserved.